Menu
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Buy Currently
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Sample Portfolio
Sample Portfolio Analysis
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Account Requirements
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
Municipal Bond Presentation
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Normally Buy
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF® Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about FMTX
Recent news which mentions FMTX
Novo Nordisk Touts Another Once-Weekly Insulin Icodec Win In Type 2 Diabetes
October 03, 2022
Tickers
FMTX
NVO
ZEAL
Tags
Market News
NVO
ZEAL
From
Benzinga
4 Analysts Have This to Say About Forma Therapeutics Hldgs
September 02, 2022
Tickers
FMTX
Tags
BZI/AAR
FMTX
Analyst Ratings
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 2, 2022
September 02, 2022
Tickers
ADN
AI
AZRE
CRM
Tags
DOW
PANW
AI
From
Benzinga
This Analyst Predicts $700 For Broadcom, Plus RBC Capital Slashes PT On This Stock By 85%
September 02, 2022
Tickers
AVGO
AZRE
CIEN
FLWS
Tags
Analyst Ratings
PT Changes
Market News
From
Benzinga
Why Snap Shares Jumped 7%; Here Are 75 Biggest Movers From Yesterday
September 02, 2022
Tickers
AGIO
AI
AMD
ATXG
Tags
HOWL
BLBX
Market News
From
Benzinga
Dow Turns Higher; Gold Down 1%
September 01, 2022
Tickers
AVCT
CDZI
EDN
FMTX
Tags
SMTC
Benzinga
Mid/Afternoon Market Update
From
Benzinga
Why Forma Therapeutics Holdings Stock Is On Fire Today
September 01, 2022
Tickers
FMTX
NVO
Tags
Market News
NVO
Recent Press Releases
From
Motley Fool
12 Health Care Stocks Moving In Thursday's Intraday Session
September 01, 2022
Tickers
BGXX
BIMI
BNR
EYEN
Tags
KRBP
BNR
NMTC
From
Benzinga
Nasdaq Tumbles 250 Points; Crude Oil Falls Sharply
September 01, 2022
Tickers
AVCT
CDZI
EDN
FMTX
Tags
Benzinga
Information Technology
Communications Equipment
From
Benzinga
Why Okta Is Trading Lower By Over 32%, Here Are 58 Stocks Moving In Thursday's Mid-Day Session
September 01, 2022
Tickers
AGIO
AI
AMD
AMZN
Tags
KERN
RIBT
PSNY
From
Benzinga
Nutanix, Five Below And Some Other Big Stocks Moving Higher On Thursday
September 01, 2022
Tickers
AGIO
BLTE
CLAR
FIVE
Tags
CLAR
FMTX
Intraday Update
From
Benzinga
Guardforce AI (GFAI) Stock Gets a Boost From New Exec Team
September 01, 2022
Tickers
FMTX
GFAI
HPCO
OKTA
Tags
NASDAQ:GFAI,NASDAQ:FMTX,NASDAQ:HPCO,NASDAQ:OKTA
OKTA
FMTX
From
InvestorPlace
Forma Therapeutics (FMTX) Stock Soars on Novo Nordisk Acquisition News
September 01, 2022
Tickers
FMTX
NVO
Tags
FMTX
NVO
Today's Market
From
InvestorPlace
After Pfizer, Now Novo Nordisk Beefs Up Its Sickle Cell Portfolio With Forma Therapeutics Deal
September 01, 2022
Tickers
FMTX
GBT
NVO
PFE
Tags
FMTX
Trading Ideas
M&A
From
Benzinga
Recap: Forma Therapeutics Q2 Earnings
August 05, 2022
Tickers
FMTX
Tags
BZI/Recaps
News
Market News
From
Benzinga
Earnings Scheduled For August 5, 2022
August 05, 2022
Tickers
ACMR
ADNT
ALDX
AMCX
Tags
SRCL
Benzinga
TSAT
From
Benzinga
Earnings Outlook For Forma Therapeutics Hldgs
August 04, 2022
Tickers
FMTX
Tags
Earnings
Benzinga
Market News
From
Benzinga
Biotech Daily: Merck's Two Combo Cancer Trials Miss Main Goal, Approval For Sinovac's COVID-19 Shot For Youngest Kids, Alnylam Aces Protein Disorder Trial
August 03, 2022
Tickers
ALNY
AMRN
ARQT
BMRN
Tags
Movers
Market News
ARQT
From
Benzinga
Rigel Pharma Expands Blood Cancer Portfolio With Forma Therapeutics Licensing Pact
August 03, 2022
Tickers
FMTX
RIGL
Tags
FMTX
Trading Ideas
Briefs
From
Benzinga
Read Why Forma Therapeutics' Current Price Level Is 'Attractive Entry Point'
June 13, 2022
Tickers
FMTX
Tags
Reiteration
FMTX
Briefs
From
Benzinga
Recap: Forma Therapeutics Hldgs Q1 Earnings
May 06, 2022
Tickers
FMTX
Tags
FMTX
Benzinga
Earnings
From
Benzinga
Earnings Scheduled For May 6, 2022
May 06, 2022
Tickers
ABR
ACMR
AES
AIM
Tags
LSXMK
BEP
CLMT
From
Benzinga
Preview: Forma Therapeutics Hldgs's Earnings
May 05, 2022
Tickers
FMTX
Tags
Earnings
BZI/EP
FMTX
From
Benzinga
Forma Therapeutics: Q4 Earnings Insights
March 01, 2022
Tickers
FMTX
Tags
Market News
BZI/Recaps
News
From
Benzinga
Earnings Scheduled For March 1, 2022
March 01, 2022
Tickers
ADT
ADV
AGEN
AIV
Tags
ATEC
MANU
BRP
From
Benzinga
The Week Ahead In Biotech (Dec. 6-Dec. 11): Daré FDA Decision, Adcom Tryst For Reata, Multiple Conference Presentations And More
December 06, 2021
Tickers
ABBV
ADCT
AGIO
ALNY
Tags
BJDX
ABBV
ATNM
From
Benzinga
The Daily Biotech Pulse: J&J To Spin-off Consumer Health Business, AstraZeneca Earnings, Embattled Emergent To Buy Back Shares
November 12, 2021
Tickers
ADPT
AFIB
ANVS
ATHX
Tags
ANVS
RGNX
CGEN
From
Benzinga
Earnings Scheduled For November 12, 2021
November 12, 2021
Tickers
AZN
BKKT
BKSY
BLX
Tags
NTCO
PLXP
NGD
From
Benzinga
The Daily Biotech Pulse: NRx Stitches COVID-19 Drug Partnership, Protara Gets Nod For Starting Bladder Cancer Study, IGM Moves Beyond Oncology
October 12, 2021
Tickers
ABSI
ADMA
ADXN
AERI
Tags
AMTI
News
RPTX
From
Benzinga
The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs
October 08, 2021
Tickers
ABIO
ADVM
AFIB
AGRX
Tags
BDTX
ATXI
CALT
From
Benzinga
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.